Ipsen : to host an Investor Day to highlight its innovative

5 new chemical entities advancing in pipeline


9 significant regulatory submissions planned from 2019 to 2022


2022 financial outlook of Group...

Related Keywords

United Kingdom , France , Paris , France General , China , Ipsen Euronext , Standard International , Group Net Sales , Core Operating , Investor Day , Chief Executive Officer , Rare Diseases , Orphan Drug , Fast Track , Breakthrough Therapy , Rare Pediatric Disease , Gastrointestinal Cancer , Systemic Radiation Therapy , Specialty Care , Net Sales , Markets ,